INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

10,888 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
51
GM
Gold Alexander MDirector
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$235K
5,000 sh
Nov 11, 2025Nov 13, 2025
Page 265 of 273
← PrevNext →
traded Nov 11, 2025
+2d
SEC Form 4

Evidence

51
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$1.42M
2,194 sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

50
GP
Gu PaulDirector, Chief Technology Offier
UPSTUpstart Holdings, Inc.
Open-market purchase
BUY$3.14M
80.0K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

50
GM
Gold Alexander MDirector
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$593K
12.7K sh
Nov 13, 2025Nov 13, 2025
traded Nov 13, 2025
+0dSEC Form 4

Evidence

49
CJ
Congleton JonDirector, Chief Executive Officer
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$5.15M
112.3K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

48
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$315K
480 sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

48
DS
Dewan SameerSenior Vice President
GGenpact LTD
Open-market sale
SELL$1.19M
26.5K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

48
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$988K
1,535 sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

47
GM
Gold Alexander MDirector
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$91K
1,933 sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC Form 4

Evidence

47
GP
Gu PaulDirector, Chief Technology Offier
UPSTUpstart Holdings, Inc.
Open-market purchase
BUY$784K
20.0K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

47
GM
Gold Alexander MDirector
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$233K
5,000 sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC Form 4

Evidence

46
LS
Levy Adam ScottCFO and Secretary
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$359K
8,485 sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

46
LS
Levy Adam ScottCFO and Secretary
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$539K
13.0K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

46
LS
Levy Adam ScottCFO and Secretary
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$382K
8,456 sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

46
LS
Levy Adam ScottCFO and Secretary
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$473K
11.3K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

45
CJ
Congleton JonDirector, Chief Executive Officer
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$1.54M
32.9K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

45
CJ
Congleton JonDirector, Chief Executive Officer
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$1.32M
29.2K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

44
WH
White HeatherSVP & Chief Legal Officer
GGenpact LTD
Open-market sale
SELL$2.09M
45.7K sh
Nov 13, 2025Nov 13, 2025
traded Nov 13, 2025
+0dSEC Form 4

Evidence

43
DA
Doudna Jennifer ADirector
TEMTempus AI, Inc.
Open-market sale
SELL$138K
1,926 sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

43
HA
Harvey Dawson AlyssaDirector
APPAppLovin Corp
Open-market sale
SELL$118K
200 sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC Form 4

Evidence

42
CR
Conrad Micah R.EVP & COO
OMFOneMain Holdings, Inc.
Open-market sale
SELL$296K
5,000 sh
Nov 7, 2025Nov 13, 2025
traded Nov 7, 2025
+6dSEC Form 4

Evidence

42
RJ
Russell Alan JDirector, Chief Scientific Officer
EWTXEdgewise Therapeutics, Inc.
Open-market sale
SELL$2.11M
100.0K sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC Form 4

Evidence

42
CJ
Congleton JonDirector, Chief Executive Officer
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$533K
12.8K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

42
CJ
Congleton JonDirector, Chief Executive Officer
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$375K
8,862 sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

41
PT
Pearson David ToddDirector, President & COO
BFSSAUL CENTERS, INC.
Open-market purchase
BUY$100K
3,348 sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC Form 4

Evidence

39
CJ
Congleton JonDirector, Chief Executive Officer
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$174K
4,000 sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

39
LS
Levy Adam ScottCFO and Secretary
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$180K
4,142 sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

39
LS
Levy Adam ScottCFO and Secretary
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$67K
1,561 sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

38
DV
Dvorkin ViktarSVP/Head of Global Delivery
EPAMEPAM Systems, Inc.
Open-market sale
SELL$448K
2,465 sh
Nov 13, 2025Nov 13, 2025
traded Nov 13, 2025
+0dSEC Form 4

Evidence

38
SM
Schlosser MarioDirector, President of Technology & CTO
OSCROscar Health, Inc.
Open-market sale
SELL$4.37M
286.2K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

38
FT
Franklin TamaraDirector
GGenpact LTD
Open-market sale
SELL$126K
2,750 sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC Form 4

Evidence

36
BM
Bendza Gary MarkEVP, CFO
TLSTELOS CORP
Open-market sale
SELL$415K
57.7K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

36
WJ
Warnick JasonChief Financial Officer
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$15.22M
114.0K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

36
GC
Goldberg ChenSVP of Engineering
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$287K
3,233 sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

36
WJ
Warnick JasonChief Financial Officer
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$11.78M
89.0K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

36
CL
Charlton Henry LEVP & Chief Commercial and Mkt
ISRGINTUITIVE SURGICAL INC
Open-market sale · 10b5-1 plan
SELL$2.74M
4,731 sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC Form 4

Evidence

36
LS
Levy Adam ScottCFO and Secretary
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$43K
1,015 sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

36
CL
Christen Timothy LDirector
EXFYExpensify, Inc.
Open-market purchase
BUY$57K
40.0K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

36
GC
Goldberg ChenSVP of Engineering
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$276K
3,013 sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

36
HW
Henderson Joseph Sean-WalshChief Accounting Officer
BKKTBakkt, Inc.
Open-market sale
SELL$1,781
95 sh
Jul 15, 2025Nov 13, 2025
traded Jul 15, 2025
+121dSEC Form 4

Evidence